GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Allmed Solutions ALMD.TA · ILA

Health Care · Tel Aviv · 🇮🇱 Israel

Compare

30.20

—

Close of 4 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in ILS, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−ILS 14.1m

FY2016FY2025

Free cash flow

−ILS 12.1m

FY2016FY2025

Shareholders' equity

ILS 25.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue————ILS 5,545ILS 9.7mILS 11.1mILS 9.3mILS 7.7mILS 7.4m
Research and developmentILS 8,019ILS 7,273ILS 6,642ILS 5,253ILS 5,440ILS 9.1mILS 143,000ILS 273,000ILS 343,000ILS 224,000
Operating income−ILS 13.0m−ILS 11,068−ILS 3,344−ILS 12,296ILS 6.2m−ILS 8.9mILS 62.5m−ILS 22.9m−ILS 22.8m−ILS 23.1m
Net income−ILS 14.1m−ILS 8,752ILS 1,422−ILS 11,193ILS 2.8m−ILS 8.7mILS 22.0m−ILS 20.2m−ILS 22.7m−ILS 23.9m
Diluted earnings per share-0.15-0.000.00-0.000.04-0.000.27-0.27-0.36-0.46

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsILS 31.5mILS 44.8mILS 59.2mILS 57.8mILS 54.8mILS 56.4mILS 67.2mILS 43.1mILS 51.9mILS 52.2m
Cash and short-term investmentsILS 29.4mILS 43.2mILS 57.1mILS 21.0mILS 15.6mILS 9.9mILS 20.1mILS 16.8mILS 23.0mILS 23.2m
Total liabilitiesILS 3.5mILS 2.8mILS 3.2mILS 3.8mILS 2.5mILS 7.6mILS 10.6mILS 10.3mILS 13.1mILS 14.0m
DebtILS 886,000ILS 619,000ILS 875,000ILS 668,000ILS 355,000ILS 2.2mILS 3.1m———
Shareholders' equityILS 25.2mILS 39.3mILS 53.4mILS 51.5mILS 50.4mILS 48.9mILS 57.4mILS 32.7mILS 38.4mILS 38.2m
Shares outstanding96m86m81m81m80m100,581m82m74m63m52m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−ILS 12.1m−ILS 8.0mILS 7.1m−ILS 10.2m−ILS 5.5m−ILS 8.8m−ILS 12.3m−ILS 16.0m−ILS 18.4m−ILS 17.3m
Capital spending−ILS 43,000−ILS 118,000−ILS 119,000−ILS 438,000−ILS 44,000−ILS 130,000−ILS 80,000−ILS 207,000−ILS 501,000−ILS 220,000
Free cash flow−ILS 12.1m−ILS 8.1mILS 7.0m−ILS 10.7m−ILS 5.5m−ILS 8.9m−ILS 12.4m−ILS 16.2m−ILS 18.9m−ILS 17.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−ILS 5.9m−ILS 2.9m−ILS 6.8m−ILS 6.2m−ILS 3,123−ILS 3,123−ILS 2,824−ILS 2,824
Net income−ILS 6.6m−ILS 3.3m−ILS 7.1m−ILS 7.0m−ILS 3,500−ILS 3,500−ILS 2,684−ILS 2,684
Diluted earnings per share-0.07-0.03-0.07-0.07-0.00-0.00-0.00-0.00
Cash from operations−ILS 5.0m−ILS 2.83bn−ILS 6.0m−ILS 3.0m−ILS 5.0m—−ILS 4.0m—
Capital spending—−ILS 11.0m——————
Free cash flow—−ILS 2.85bn——————
Total assetsILS 26.3mILS 26.3mILS 31.5mILS 31.5mILS 37.6mILS 37.6mILS 44.8mILS 44.8m
Cash and short-term investmentsILS 24.3mILS 24.3mILS 29.4mILS 29.4mILS 36.0mILS 36.0mILS 43.2mILS 43.2m
DebtILS 327,000ILS 327,000ILS 359,000ILS 359,000ILS 445,000ILS 445,000ILS 384,000ILS 384,000
Shareholders' equityILS 20.7mILS 20.7mILS 25.2mILS 25.2mILS 32.3mILS 32.3mILS 39.3mILS 39.3m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income919.2%7.8%-3.8%
Net income980.6%10.3%-3.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings-2.4-3293.4-1780.612.6-6226.81.9-2.0-3.3-2.5-2495.9
Price to sales—————3.64.59.88.2—

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-to-1 reverse split · 22 Feb 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.